Oxford Nanopore Technologies Plc logo

Oxford Nanopore Technologies Plc(LSE) ONT

Market Cap£2.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-65%
5 Year-63%
1 Year+45%
1 Month+34%
£2.11
-2.77%
-0.06Today
Oxford Nanopore Technologies Plc last closing stock price
MetricPriceDate
Last closeGBX 211.002026-10-13
Oxford Nanopore Technologies Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.58%GBX 230.802026-10-06
1 month+34.48%GBX 156.902026-09-11
3 month+85.9%GBX 113.502026-07-15
Year to date+64.33%GBX 128.402025-12-31
1 year+44.72%GBX 145.802025-10-13
3 year+6.57%GBX 198.002023-10-13
5 year-62.98%GBX 570.002021-10-14
Since inception-64.58%GBX 6.132021-09-30

Oxford Nanopore Technologies Plc Financials at a Glance

Market Cap

£2.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£439.71M

Net Income (TTM)

-£264.74M

EPS (TTM)

-£0.13

P/E Ratio

-17.28

Dividend

£0.00

Beta (Volatility)

0.03 (Low)

Price

£2.11

Volume

2,840,055

Open

£2.19

Previous Close

£2.11

Daily Range

£2.11 - £2.19

52-Week Range

£0.96 - £2.39

Estimated Earnings Date

Mar 9, 2027

ONT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc is a pioneering biotechnology company based in the United Kingdom, specializing in innovative systems for analyzing molecular structures through nanopore-based sensing. The company offers a range of portable and benchtop sequencing devices, enabling real-time analysis of DNA and RNA.

Products and Services
  • MinION: A portable device for DNA and RNA sequencing
  • GridION: A benchtop sequencer for multiple flow cells
  • EPI2ME: A cloud-based platform for real-time data analysis
Growth Outlook
  • Recent quarterly revenue reached £116.7 million, indicating strong market demand
  • TTM revenue of £528 million shows significant growth potential
  • Continued development of new products like MinION Mk1D and Ubi enhances future prospects
Financial Highlights
  • Net income for Q2 2026 was -£48 million, reflecting ongoing investment in R&D
  • Cash and short-term investments totaled £184.8 million, providing liquidity for operations
  • Gross profit margin improved to 62.2% in Q2 2026, indicating operational efficiency
Oxford Nanopore Technologies is positioned at the forefront of genomic sequencing technology, with a diverse product portfolio that caters to various market needs. The company's innovative approach to sequencing has garnered attention, leading to substantial revenue growth. Despite recent net losses, the strong cash position and improving gross margins suggest a focus on long-term growth and sustainability. The ongoing development of new products further enhances the company's potential to capture market share in the rapidly evolving biotechnology sector.
AI Generated • Sep 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

1,403

CEO

Gordon Sanghera, PhD

Website

nanoporetech.com

Headquarters

Oxford, OX OX4 4DQ, GB

ONT Financials

Key Financial Metrics (TTM)

Gross Margin

60.18%

Operating Margin

-58.06%

Net Income Margin

-54.66%

Return on Equity

-35.45%

Return on Capital

-30.76%

Return on Assets

-27.82%

Earnings Yield

-5.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£2.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

978.45M

Volume

2.84M

Avg. Volume

2.86M

Financials (TTM)

Gross Profit

£259.83M

Operating Income

-£281.31M

EBITDA

-£179.31M

Operating Cash Flow

-£132.11M

Capital Expenditure

-£13.54M

Free Cash Flow

-£145.66M

Cash & ST Invst.

£184.80M

Total Debt

£41.80M

Oxford Nanopore Technologies Plc Performance Analysis

Oxford Nanopore Technologies Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 198,603,00048.6%
20232023-12-31GBP 169,668,000-14.6%
20242024-12-31GBP 183,191,0008.0%
20252025-12-31GBP 223,900,00022.2%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3117.9%
Q22025-06-30-46.7%
Q42025-12-31224.1%
Q22026-06-30-31.8%
Oxford Nanopore Technologies Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.11-45.8%
20232023-12-31GBP -0.1967.7%
20242024-12-31GBP -0.16-12.1%
20252025-12-31GBP -0.15-7.2%
Oxford Nanopore Technologies Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3111.5%
Q22025-06-3051.0%
Q42025-12-31-193.3%
Q22026-06-3055.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£116.70M

+38.8%

Gross Profit

£72.60M

+46.8%

Gross Margin

62.21%

N/A

Market Cap

£2.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£1.62M

N/A

Employees

1,314

N/A

Net Income

-£48.00M

+35.7%

EBITDA

-£22.00M

+61.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£184.80M

-28.6%

Total Debt

£41.80M

-10.5%

Accounts Receivable

£92.60M

+51.7%

Inventory

£80.40M

-25.6%

Long Term Debt

£36.10M

-13.2%

Short Term Debt

£5.70M

+11.2%

Return on Assets

-27.82%

N/A

Return on Invested Capital

-36.03%

N/A

Free Cash Flow

-£41.50M

+35.9%

Operating Cash Flow

-£39.40M

+28.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EKF.LEKF Diagnostics Holdings plc
£0.26-1.92%
ABDX.LAbingdon Health Plc
£0.10-11.63%
GDR.LGenedrive Plc
£0.01-2.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About ONT

What is the current price of Oxford Nanopore Technologies Plc?

Oxford Nanopore Technologies Plc is trading at £2.11 per share.

What is the 52-week range for Oxford Nanopore Technologies Plc?

Over the past 52 weeks, Oxford Nanopore Technologies Plc has traded between £0.96 and £2.39.

How much debt does Oxford Nanopore Technologies Plc have?

As of the most recent reporting period, Oxford Nanopore Technologies Plc reported total debt of £41.50M.

How much cash does Oxford Nanopore Technologies Plc have on hand?

Oxford Nanopore Technologies Plc reported £181.10M in cash and cash equivalents in its most recent financial results.

What is Oxford Nanopore Technologies Plc’s dividend yield?

Oxford Nanopore Technologies Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services